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wa~ performed by using CAPS II system. As of August '95,175 lesions (70%) 
out of 250 screened lesions underwent successful dilatation by 1.5 mm 
balloons. Sixty lesions (34%) were randomized (vessel size ~ 2.5 mm and 
lesion length _< 30 mm by visual estimation) (Balloon (BA) group 30, ST group 
30). All procedures in the CS group were successful without any evidence 
of subacute steel thrombosis, Multiple Stans were used in 17 lesions (57%). 
In the BA group, 9 lesions (30%) requimcl bail-out CS due to delayed distal 
flow(2 lesions)and residual stenosis > 50% (7 lesions) (% diameter stenosis 
74 :l: 5.2% (67-81)). In additional 2 lesions (9%), CS was performed due to 
reocclusion at 24 hours study, 
ST (n = 30) BA (n = 30) P value 
Proximal RD (~'m) 3.14 ± 0.35 2.97 ~ 0.36 NS 
MLD (post) 2,29 :t: 0.47 1.87 ± 0.40 <0.001 
MLD (24 hi's) 2.23 ± 0.41 1.63 ± 0.64 <0.001 
MLD (3-6 M) 1.57 ± 0.60 1.60 -*- 0.72 NS 
Binary restenosls (%) 36 (9/25) 33 (8/24) NS 
TLR (%) 3-" (7/25) 29 (7/24) NS 
RD:  Reference diameter (ram), MLD: Minimal umen diameter (ram), TLR: Target lesion 
revascularizatioe. 
Thus, CS was effective in preventing eady reocolusion and associated with 
larger post and 24 hours MLD. This favorable acute luminal outcome over 
BA was not sustained at 3-6  months follow-up. BA supported by bail-out CS 
was equally effective as elective CS in the management of TO. 
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~ Coronary Staining Following Successful 
Angioplasty for Total Occlusions: Preliminary 
Results of a Randomlead Trial 
Martyn Thomas, Jane Hancock, Steve Holmberg, Ray W~nwright, 
David Jewitt, Oept of CardiG/ogy, King's College Hospital, UK 
The medium term results of balloon angioplasty for total coronary occlusions 
are ,oDor because of high reoccfusion [RO ! and restenosis [RSi rates. The 
angiographic (minimal luminal diameter [MLD], RO, RS and ejection fraction 
[El=l) and clinical (q~t PTCA, CABG and death) benefit of sleet deployment 
at the occlusion site is unknown. We have rendomised 60 patients to "no 
steel" (Gp A) or'sight" (Gp B) following successful PTCA of a total occlusion. 
Time of occlusion was similar in Gp A and Gp B (9 ± 10 v 14 ± 17 weeks 
respectively, NS). Post procedure angiographic results were significantly 
better in Gp B. 
EF Ret MLD % Stenosis 
Gp A (n = 30) 53.1% ~.5 mm 2.8 mm 19.1% 
Gp B (n = 30) 59.6 % 3.3 mm 3.3 mm - t .1% 
p value NS NS p < 0.01 p < 0.001 
There was no clinical in,patient vessel closure. Six month angiographic 
data is currently available in 40 patients. Coronary patency, residual % 
stenosis and EF is significantly belte, in Gp B. MLD is not statistically different 
in Gp A (1.5 ± 1.3 ram) and Gp B (2.0 ± 1.0 ram). 
EF RO RS % stenosis 
Gp A (n = 20) 58.0 % 6/20 6/20 60.0% 
Gp B (n = 20) 70.1% 1/20 4/20 37.8% 
p value p < 0.05 p < 0.05 NS p < 0.05 
Clinical events in the 2 groups is similar (mean follow up 37 weeks), 
Rpt PTGA CABG Death 
GP A (~ = 30) 4/30 2/30 1/30 
Gp B (n = 30) 2/30 1/30 0/30 
Six month results of this randomised study indicate a significant benefit in 
patency, residual % stenosis and left ventricular function if a stent is deployed 
at the site of occlusion following successful PTCA. 
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~The for Treating Calcilied Lesions Optimal Strategy 
in Large Vessels: Comparison of Intravascular 
Ultrasound Results of Rotational Atherectomy + 
Adjunctive PTCA, DCA, or Stems 
Gaston R. Dussaiiiant, Gary S. Mintz, Augusto D. Pichard, Kenneth 
M. Kent, Lowell F, Sailer, Jeffrey J, Popma, Carol Wa'-h, Paul Mackel, 
Jennifer Griffin, Kathy Morgan, Tammy Weaver, Martir, % Leon. Washi.'Pgton 
Hospital Center, Washington DC 
Treatment results of rotational athemctomy (RA) in calcified lesions in large 
(> 3 ram) vessals are frequently suboptimal. To determine the best adjuno- 
live device after RA, wo compared acute tntravascular ultrasound results 
(measurement of final lumen area and final diameter stenosis) following RA 
and adjunctive PTCA (N = 235), DCA (N = 120), or Palmaz-Schatz stents (N 
= 83) in lesions matched for reference lumen area and total and superficial 
lesion calcium (Ca): 
RA+ RA+ RA+ Anova 
PTCA DCA Stem p 
Reference lumen area (ram 2) 9.1 ~ 2.5 9.5 • 2.9 9.5 ± 3.0 0.3102 
Total arc of Ca (~) 200±113 201±63 212±105 0.6372 
Arc 0f superficial Ca ( a ) 175±119 175+108 159±120 0.6300 
Real lumen area (ram 2 ) 5.0±1.4 6.5 ~: 1.9 7.1 :E 2.0 <0.0001 
Final diarnetar stsnosia (%) 24±13 16±13 12±12 ~0.0001 
Final lumen area was 300 larger with RA + DCA and 42% larger with RA 
+ Stent than with RA + PTCA. Final DS was 33°/,= smaller with RA + DCA 
and 50°/, smaller with RA + Steel than with RA + PTCA. Furthermore, there 
were no procedural complications (including perforation), no subacute stent 
thrombosis, no major in-hospital complications, and only one 30 day clinical 
event (death due to noncardiae multisystam failure) after RA + Stsnt. We 
conclude: In > 3 mm vessels with calcified lesions, RA + Stent achieves the 
largest lumen and smallest DS (vs RA + PTCA or RA + DCA). Late fcllow-up 
will determine if the superior acute lumen dimensions after RA ÷ Stent result 
in fewer subsequent revascutarization events. 
PTCA in Acute Myocardial Infarction and the 
Influence of Gender on Outcome 
Tuesday, March 26, 1996, 10:30 a.m.-Noon 
Orange County Convention Center, Room 414B 
10:30 
[:Z'-43--'~ Determinants of 30 day and I Year Morlaiity in Acute 
Myocardial Infarction: Benefit of Early Angiography 
Conor F. Lundergan, Jonathan S. Reiner, Allan M. Ross. George 
Washington University, Washington, D.C. 
Independent clinical predictom of 30 day and I year mortality in acute my- 
ocardiat infarction (AMI) have been described previously and have shown 
expected (e.g., age) and unexpected (e.g., height} predictors of mortality. The 
GUSTO-1 Angiographic Tnal data base was used to determine the contn'bu- 
tion of clinical and angiographic variables to 30 day and one year mortality 
by logistic regression analysis in 1L:~O0 patients with 90 minute post treatment 
angiogrsphy. Variables considered to be related to mortality (age, gender, 
diabetes, time to treatment, history of hypertension or previous MI, body 
weight, infarct site, Killip class) were entered into the model in a step~se 
fashion and significance determined. Angiographic v,~riables included infarct 
related arlery (IRA) 90 minute TIMI (0.1 vs 2.3) flow grade, # of diseased 
vessels anti one week post AMI ejection fraction (EF). Independent deter- 
minants of 30 day and one year mortality were: (RR = relative risk; CI = 
contidance limit; NS = not signWc, ant) 
30 Day Mo,'laBty One Year Morlality 
RR 95% CI RR 95% Ct 
Age (< 78, _> 75) 3.8 (23, 6.7) 4.0 (2.5, 6.4) 
Female 2.5 (1.5, 4.2) NS 
Diabete,~ NS 1.7 (1.0, 2.9) 
Body Weight NS 0.97 (0.96, 0.98) 
Mul]ivessel CAD 1.9 (1.2,3.2) 2.0 (1_o.3.1) 
TIMI Flow 3.9 (2.4, 6.6) 2.6 (1.7, 4.2) 
EF (<_ 40, > 40) 3.0 (1.7, 5.5) 3.7 (2.2, 6.0) 
Conc/us/ons: 1. Angiographic variables add significant prognostic informa- 
tion to early and late mortality prediction in AMI beyond that provided by 
clinical variables alone. 2. These data suggest treatment strategies for AM1 
should incorporate determination of eady IRA patency to assess treatment 
efficacy and passsibly optimize Outcome. 3. Early IRA patency improves 
e,=ly and late survival independent of El:. 
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ImprovPs Long-Term Survival: PAMI-1 Follow-up 
Christopher Nunn, William O'NeilL Donald Rothbaum, James O'Keefe, Jr., 
Paul Ovedie, Bryan Donohue, Denise Mason, Tom Catiin, Cindy Grines. 
William Beaumont Hospital, Royal Oak, MI 
Randomized ldals of PTCA vemus thrombolytic therapy for acute myocardial 
